Navigation Links
Zambia to Get Anti-AIDS Drug Boost from Global Fund

Former US president Bill Clinton will visit Zambia this weekend to boost an UN-backed HIV/AIDS drugs programme which is helping treat some 13,250 children, UNITAID said Thursday.

The partnership between the Bill Clinton Foundation and UNITAID, a international drugs funding initiative, has increased the number of children under life-saving treatment in Zambia by about 7,200, an agency spokeswoman said.

With current levels of the disease, youngsters in Zambia face a 50 percent life-time risk of dying of AIDS in the absence of treatment, according to United Nations.

The Zambian government is also due to sign up to a five million dollar UNITAID programme to finance costly second line antiretroviral drugs in Zambia, one of the countries worst affected by HIV/AIDS.

UNITAID was launched last year by Brazil, Britain, France, Chile, Norway as an international drug purchasing facility for poor countries, partly funded by airline ticket levies.

At least 34 countries have signed up as donors to the 300 million dollar fund, which is aiming to help treat an additional 100,000 child HIV/AIDS victims in the world this year, and provide drugs against other major diseases.

UNITAID board chief Philippe Douste-Blazy is also due to discuss the supply of new artemisin-based anti-malarial and tuberculosis drugs with Zambian officials.

Although not part of the United Nations, the organization is backed by the World Health Organization.


Page: 1

Related medicine news :

1. Herbal remedies to be tested by Zambia for AIDS treatment
2. Pharmaco in Zambia Scrutinizes the Side Effects of Medicines Launched In the Market
3. Bird Flu In Zambia-Panic Among Locals
4. Zambia Struggling To Identify AIDS Sufferers
5. The Aids Programme In Zambia Reported As A Success
6. PEPFAR to help Zambias efforts to fight AIDS
7. Zambia Trying Hard to Tackle Crisis in Mental Health Care
8. Diagnostic Tests for Malaria Underused in Zambia
9. Recall of the AIDS Drug Causes Panic in Zambia
10. Zambia Opens First Cancer Hospital
11. Use Of Viread Spreads As New Anti-AIDS Site Is Launched
Post Your Comments:

(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: